Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma

URN to cite this document:: urn:nbn:de:bvb:355-epub-515016
DOI to cite this document:: 10.5283/epub.51501

Schulz, Daniela ; Wetzel, Martin ; Eichberger, Jonas ; Piendl, Gerhard ; Brockhoff, Gero

; Wege, Anja K.

; Reichert, Torsten ; Ettl, Tobias ; Bauer, Richard J.

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 25 Jan 2022 12:43

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

The expression of PD-L1 by tumor cells is mainly associated with its immunosuppressive effect. In fact, PD-1/PD-L1 immune checkpoint inhibitors demonstrated remarkable effects in advanced cancer patients including HNSCC. In this context, irradiation is currently being investigated as a synergistic treatment modality to immunotherapy. However, the majority of HNSCC patients still show little ...